Log In
BCIQ
Print this Print this
 

SYN-010

  Manage Alerts
Collapse Summary General Information
Company Synthetic Biologics Inc.
DescriptionOral modified-release formulation of lovastatin, an HMG-CoA reductase inhibitor
Molecular Target HMG-CoA reductase
Mechanism of ActionHMG-CoA reductase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome with constipation (IBS-C)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today